The initial success of the copyright undeniably transformed the drug landscape, but betting in companies primarily reliant on unbranded versions presents a uncertain picture. Although early profits were significant, the end of patents and the rise of less expensive alternatives have diminished sales. Therefore, a thorough evaluation of present f… Read More